The use of
neodymium,
holmium and
diode lasers proved highly-effective in the treatment of facial
skin cancers stage I-II (3,051)( basalioma--2,804, recurrent basalioma--165, squamous cell tumor--82) and benign
tumors (2,157). Relapsed basaliomas
after treatment from Pulsar-1,000 Ladoga-
neodymium were reported in 1.6 and 3%, respectively. When pulsed
neodymium lasers were used, repeat relapsed basalioma and recurrences of
squamous cell cancer were detected in 4.2 and 4.9%, respectively. Overall
malignancy recurrence frequency was 2,0% which was less than that after
radiotherapy and surgery. Since the radiation penetration capacity of
neodymium lasers is relatively high, their application is preferable in treatment of facial
skin cancer stage I-II as well as exophytic or in-depth benign
tumors.
Holmium and
diode lasers are better suited for destruction of superficial benign
tumors. Good results should not be expected unless the right choice of radiation modality parameters, which take account of
tumor localization and
clinical course pattern, is made.